NA

Nadancheri Padikkal Padath Ajith - Profile

Nadancheri Padikkal Padath Ajith, Director and Nominee Director, with 6 companies.

About Nadancheri Padikkal Padath Ajith

Nadancheri Padikkal Padath Ajith has 21 years in corporate governance. Holds Director and Nominee Director roles. Currently with 2 companies, including Elma Pharmaceuticals Private Limited and Munus Pharmaceuticals Private Limited. Formerly with 4 companies, such as Ebc Pharmaceuticals Private Limited and Elma Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Current Companies 2
Past Companies 4
Total Affiliations 6
Oldest Company Age 21
Companies Associated with Nadancheri Padikkal Padath Ajith
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Nadancheri Padikkal Padath Ajith?

Nadancheri Padikkal Padath Ajith has 21 years in corporate governance. Holds Director and Nominee Director roles. Currently with 2 companies, including Elma Pharmaceuticals Private Limited and Munus Pharmaceuticals Private Limited. Formerly with 4 companies, such as Ebc Pharmaceuticals Private Limited and Elma Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

What is Nadancheri Padikkal Padath Ajith's role in current companies?

Nadancheri Padikkal Padath Ajith is associated with 2 companies as Director and Nominee Director.

What industries does Nadancheri Padikkal Padath Ajith specialize in?

Nadancheri Padikkal Padath Ajith has expertise in General Business.

How many years of experience does Nadancheri Padikkal Padath Ajith have?

Nadancheri Padikkal Padath Ajith has 21 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available